Your browser doesn't support javascript.
loading
Minimally Invasive Tissue Sampling: A Tool to Guide Efforts to Reduce AIDS-Related Mortality in Resource-Limited Settings
Letang, Emilio; Rakislova, Natalia; Martinez, Miguel J; Hurtado, Juan Carlos; Carrilho, Carla; Bene, Rosa; Mandomando , Inacio; Nhampossa , Tacilta; Chicamba , Valéria; Luis, Elvira; Ismail, Mamudo R; Fernandes , Fabiola; Lorenzoni, Cesaltina; Ferreira , Luiz; Freire, Monique; Calvo, Maria Teresa Rodrigo; Guerrero, José; Munguambe, Khátia; Maixenchs, Maria; Navarro , Mireia; Casas, Isaac; Marimon, Lorena; Macete, Eusebio; Lacerda, Marcus; Bassat, Quique; Ordi , Jaume.
Affiliation
  • Letang, Emilio; ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. Department of Infectious Diseases, Hospital del Mar, Hospital del Mar Research Institute, Barcelona, Spain. Barcelona. ES
  • Rakislova, Natalia; ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. Department of Pathology, Hospital Clínic, Universitat de Barcelona, Spain. Barcelona. ES
  • Martinez, Miguel J; ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. Department of Microbiology, Hospital Clínic, Universitat de Barcelona, Spain. Barcelona. ES
  • Hurtado, Juan Carlos; ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. Department of Microbiology, Hospital Clínic, Universitat de Barcelona, Spain. Barcelona. ES
  • Carrilho, Carla; Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique. Department of Pathology, Maputo Central Hospital, Maputo, Mozambique. Maputo. MZ
  • Bene, Rosa; Department of Medicine, Maputo Central Hospital, Maputo, Mozambique. Maputo. MZ
  • Mandomando , Inacio; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique. Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique. Maputo. MZ
  • Nhampossa , Tacilta; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique. Department of Pediatrics, Maputo Central Hospital, Maputo, Mozambique. Maputo. MZ
  • Chicamba , Valéria; Department of Pediatrics, Maputo Central Hospital, Maputo, Mozambique. Maputo. MZ
  • Luis, Elvira; ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. Barcelona. ES
  • Ismail, Mamudo R; Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique. 6Department of Pathology, Maputo Central Hospital, Maputo, Mozambique. Maputo. MZ
  • Fernandes , Fabiola; Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique. Department of Pathology, Maputo Central Hospital, Maputo, Mozambique. Maputo. MZ
  • Lorenzoni, Cesaltina; Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique. Department of Pathology, Maputo Central Hospital, Maputo, Mozambique. Maputo. MZ
  • Ferreira , Luiz; Fundação de Medicina Tropical Dr. Heitor Viera Dourado, Manaus, Amazonas, Brazil. Amazonas. BR
  • Freire, Monique; Fundação de Medicina Tropical Dr. Heitor Viera Dourado, Manaus, Amazonas, Brazil. Fundação Centro de Controle de Oncologia do Amazonas, Manaus, Amazonas, Brazil. amazonas. BR
  • Calvo, Maria Teresa Rodrigo; Department of Pathology, Hospital Clínic, Universitat de Barcelona, Spain. Barcelona. ES
  • Guerrero, José; Department of Pathology, Hospital Clínic, Universitat de Barcelona, Spain. Barcelona. ES
  • Munguambe, Khátia; Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique. Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique. Maputo. MZ
  • Maixenchs, Maria; ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique. Barcelona. ES
  • Navarro , Mireia; ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. Department of Microbiology, Hospital Clínic, Universitat de Barcelona, Spain. Barcelona. ES
  • Casas, Isaac; ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. Department of Microbiology, Hospital Clínic, Universitat de Barcelona, Spain. Barcelona. ES
  • Marimon, Lorena; ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. Barcelona. ES
  • Macete, Eusebio; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique. Maputo. MZ
  • Lacerda, Marcus; Fundação de Medicina Tropical Dr. Heitor Viera Dourado, Manaus, Amazonas, Brazil. Amazonas. BR
  • Bassat, Quique; ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Barcelona. ES
  • Ordi , Jaume; ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. Department of Pathology, Hospital Clínic, Universitat de Barcelona, Spain. Barcelona. ES
Clin. infect. dis ; 73(5): [343-350], 20210901. tab, ilus
Article de En | RSDM | ID: biblio-1527126
Bibliothèque responsable: MZ1.1
ABSTRACT
Available information on the causes of death among people living with human immunodeficiency virus (PLHIV) in low- and middle-income countries (LMICs) remains scarce. We aimed to provide data on causes of death in PLHIV from two LMICs, Brazil and Mozambique, to assess the impact of clinical misdiagnosis on mortality rates and to evaluate the accuracy of minimally invasive tissue sampling (MITS) in determining the cause of death in PLHIV.

Methods:

We performed coupled MITS and complete autopsy on 164 deceased PLHIV (18 children, 36 maternal deaths, and 110 adults). HIV antibody levels and HIV RNA viral loads were determined from postmortem serum samples.

Results:

Tuberculosis (22.7%), toxoplasmosis (13.9%), bacterial infections (13.9%), and cryptococcosis (10.9%) were the leading causes of death in adults. In maternal deaths, tuberculosis (13.9%), bacterial infections (13.9%), cryptococcosis (11.1%), and cerebral malaria (8.3%) were the most frequent infections, whereas viral infections, particularly cytomegalovirus (38.9%), bacterial infections (27.8%), pneumocystosis (11.1%), and HIV-associated malignant neoplasms (11.1%) were the leading cause among children. Agreement between the MITS and the complete autopsy was 100% in children, 91% in adults, and 78% in maternal deaths. The MITS correctly identified the microorganism causing death in 89% of cases.

Conclusions:

Postmortem studies provide highly granular data on the causes of death in PLHIV. The inaccuracy of clinical diagnosis may play a significant role in the high mortality rates observed among PLHIV in LMICs. MITS might be helpful in monitoring the causes of death in PLHIV and in highlighting the gaps in the management of the infections.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 06-national / MZ Base de données: RSDM Sujet principal: Infections à VIH / Syndrome d'immunodéficience acquise / VIH (Virus de l'Immunodéficience Humaine) Limites: Humans Langue: En Journal: Clin. infect. dis Année: 2021 Type de document: Article

Texte intégral: 1 Collection: 06-national / MZ Base de données: RSDM Sujet principal: Infections à VIH / Syndrome d'immunodéficience acquise / VIH (Virus de l'Immunodéficience Humaine) Limites: Humans Langue: En Journal: Clin. infect. dis Année: 2021 Type de document: Article